We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Rescentris Electronic Lab Notebook Introduces Chemistry Capabilities with ChemAxon Partnership

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

The Rescentris Electronic Lab Notebook now offers the chemical drawing and editing capabilities of ChemAxon’s Marvin, and the chemical structure management and search of ChemAxon’s JChem Base

The Rescentris CERF Chemistry Edition will further expand Rescentris’ reach as a multi-disciplinary discovery platform.

"Today’s life scientists need a knowledge platform that increases the efficiency of their research dollars and improves overall R&D performance," says Rescentris’ CEO, Adel Mikhail.

"Scientists need to manage their assay data, protocols, and chemical structures in the same application. Biological and chemical intellectual property needs to be captured and managed in the same solution."

ChemAxon has partnered to make its tools and API’s available in CERF, the Rescentris Collaborative Electronic Research Framework.

Ferenc Csizmadia, ChemAxon CEO, commented, "We are happy to see this partnership as it will immediately bring enterprise chemistry functionality to the Rescentris ELN for biology and broaden the offering across multi-disciplinary life science R&D."

The partnership with ChemAxon enables CERF to further improve productivity, quality, and decision making for both scientists and project managers.

CERF uses ChemAxon’s Marvin and JChem to enable chemistry in its Electronic Lab Notebook.

Marvin allows users to build chemical structures and reactions and to view live chemical objects within their workspace.

The JChem Base toolkit is designed to provide precision to register, manage and search chemical structures throughout an organization’s chemical IP.

In the future, clustering, virtual library enumeration, screening and drug design capabilities can be rolled out to Rescentris’ CERF users to ensure the relevance of CERF to chemical and life science research.